MedTech
Jan 18, 2023
How Are Innovations in Drug Delivery Devices Solving the Complex Challenges in the Market?
Drug delivery is one of the highly evolving topics in the healthcare industry. Over the past few decades, there has been enormous growth in the drug delivery devices market owing to the active participation of the global MedTech giants, the rise in investments, and technological advancements in the development of n...
Read More...
Dec 29, 2022
PAVmed-Novosound’s Partnership; J&J Acquires Abiomed; Approval to Sysmex’s Assay Kit to Identify Amyloid Beta (Aβ) Accumulation; SI-BONE Announced FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite Implant System; EOFlow’s Wearable Insulin Pump ‘EOPatch’; Icecure’s ProSense System, a Cryoablation Therapy
PAVmed Entered into a Partnership with Novosound for Ultrasound Imaging Technology On December 22, 2022, PAVmed Inc., a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, announced that the company has entered into a partnership with...
Read More...
Dec 28, 2022
How is Active Implantable Medical Devices Market Evolving?
Over the past few years, the growth and development in electronics, micro and nano-fabrication, and wireless technology have significantly enhanced the quality and effectiveness of healthcare delivery systems, and treatment outcomes and led to various insights in the biological investigations through research and d...
Read More...
Dec 22, 2022
Medtronic’s Hugo Robotic-Assisted Surgery System Trial; Insightec’s Pivotal LIBERATE Clinical Trial; FDA Granted EMA for Thermo Fisher Scientific’s Monkeypox Test; Life Spine’s Trulift Lateral Expandable Spacer System & Lateral Pate System; Fujifilm & Inspirata Announces Asset Purchase Agreement; Abbott Launched SCS System for Chronic Pain
Medtronic Announced First Patient Enrolment for Hugo™ Robotic-Assisted Surgery System in US Clinical Trial On December 15, 2022, Medtronic, a global healthcare technology leader, announced that the first patient was enrolled in the Expand URO US clinical trial for the Hugo™ robotic-assisted surgery...
Read More...
Dec 14, 2022
Evaluating the Impact of Clinical Decision Support Systems (CDSS) on Health Outcomes
Clinical Decision Support Systems (CDSS) is one of the most anticipated health technologies that tend to transform treatment dynamics and the healthcare market outlook. With the ongoing development, the CDSS is expected to hold immense potential to bridge the gap between the available patient data and healthcare ex...
Read More...
Dec 08, 2022
Olympus Launches New Gynecologic Power Morcellator; Journey Biosciences Launched NaviDKD; GE Board Approves Separation of GE HealthCare; FDA Approval to Enovis’s STAR Ankle; FDA Clearance to Deep Blue Medical’s T-Line Hernia Mesh; NeuroOne Completed Feasibility Study with its OneRF Ablation System
Olympus Launches New Gynecologic Power Morcellator for Its Contained Tissue Extraction System On November 30, 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, launched the moresolution™ Power Morcellator, manufactured by TROKAM...
Read More...
Nov 24, 2022
Mainstay Medical’s ReActiv8-C Study; Swing Therapeutics Announced Results from Studies of Stanza; FDA Approves Empatica’s Health Monitoring Platform; FDA Clearance to Persona OsseoTi Keel Tibia System; ClariPi Joins Siemens Healthineers Digital Marketplace; Sony Launches Cloud-based Solution for Flow Cytometry Data Analysis
Mainstay Medical Published Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study On November 22, 2022, Mainstay Medical, a medical devices company, announced that the data from the ReActiv8®-C study, a single-centre, real-world study with a one-year clinical follow-up of selected patients, is publ...
Read More...
Nov 10, 2022
QuantuMDx & Menarini’s Agreement; TruClear System Launched by Medtronic in India; FDA 510(k) Clearance for TriVerse Primary Knee Replacement System; FDA Clearance to ProciseDx’s Reactive Protein (CRP) Assay and ProciseDx Instrument; Evolution Optiks’s Enrollment of LFR-260 Phoropter in US; Kardium First-in-Human Clinical Study of the New Globe Pulsed Field System
QuantuMDx and Menarini Announced an Agreement for the Distribution of the Q-POCTM Platform On November 2, 2022, QuantuMDx Group Limited, a UK-based developer of transformational Point-of-Need molecular diagnostics, and A.Menarini Diagnostics S.r.I. (Menarini), announced an exclusive distribution agreement for Qu...
Read More...
Nov 02, 2022
How are Technological Trends and Innovations Reshaping the Dementia Care?
Dementia is a leading neurological condition that affects the brain and worsens over time. It leads to progressive cognitive and functional degeneration and results in several neuropsychiatric symptoms. As per the estimate, about 55 million people globally live with dementia, and around 10 million new cases are obs...
Read More...
Oct 26, 2022
Navigating the Emerging Trends and Technologies in the Spinal Cord Injury Rehabilitation Segment
The incidence and prevalence of traumatic spinal cord injury (SCI) worldwide have increased over time. As per the study by Weizhong Ding et al., globally, there were 0.9 million incident cases, 20.6 million prevalent cases, and 6.2 million YLDs of total SCI in 2019. Similarly, as per the data presented by WHO, ever...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
